As of 2026-03-23, the Intrinsic Value of Fulcrum Therapeutics Inc (FULC) is -3.56 USD. This FULC valuation is based on the model Peter Lynch Fair Value. With the current market price of 6.77 USD, the upside of Fulcrum Therapeutics Inc is -152.58%.
Based on its market price of 6.77 USD and our intrinsic valuation, Fulcrum Therapeutics Inc (FULC) is overvalued by 152.58%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -3.56 - -3.56 | -3.56 | -152.58% |
| P/E | (7.53) - (11.78) | (10.79) | -259.3% |
| DDM - Stable | (5.99) - (21.80) | (13.89) | -305.2% |
| DDM - Multi | (1.21) - (3.51) | (1.81) | -126.7% |
| Market Cap (mil) | 544.12 |
| Beta | 1.69 |
| Outstanding shares (mil) | 80.37 |
| Enterprise Value (mil) | 346.59 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.63% |
| Cost of Debt | 5.00% |
| WACC | 6.65% |